EventsThe 1st International Online Conference on Diagnostics
Published
This submission belongs to the session S4. Clinical Diagnosis and Prognosis of the event The 1st International Online Conference on Diagnostics
Published date
18 Sep, 2026
Academic Editor
author-avatarGiorgio Treglia
Citation
Bruno Cesar da Costa, Cintia Eliza Marques, Natalie Aparecida Rodrigues Fernandes, Katja Korelin, Fábio Haach Téo, Everton Freitas de Morais, Tuula Salo, Ahmed Al-Samadi, Ricardo Della Coletta, IL-17RC is associated with improved survival and modulates tumor cell phenotypes in oral squamous cell carcinoma, in Proceedings of The 1st International Online Conference on Diagnostics, 23 September–24 September 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

IL-17RC is associated with improved survival and modulates tumor cell phenotypes in oral squamous cell carcinoma

Cintia Eliza Marques 1
Natalie Aparecida Rodrigues Fernandes 2
Katja Korelin 2,3
Fábio Haach Téo 4
image
image
1. Graduate Program in Oral Biology, Piracicaba Dental School, University of Campinas, 13414-903 Piracicaba, São Paulo
2. Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, 00014 Helsinki
3. Translational Immunology Research Programme (TRIMM), University of Helsinki, 00014 Helsinki
4. Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, 13414-903 Piracicaba, São Paulo
5. Graduate Program in Biotechnology, Federal University of Ceará, 62042-280 Sobral, Ceará
6. Cancer and Translational Medicine Research Unit, University of Oulu, 90014 Oulu
7. Institute of Dentistry, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio
Abstract

Oral squamous cell carcinoma (OSCC) exhibits marked biological heterogeneity, resulting in variable clinical outcomes and limited therapeutic response. Recent evidence has highlighted the involvement of interleukin-17 family cytokines in several cancer types. However, the role of the interleukin-17 receptor C (IL-17RC) in OSCC remains unexplored. Therefore, this study aimed to investigate the prognostic value and biological role of IL-17RC in OSCC.
A retrospective immunohistochemical analysis was performed on 235 OSCC specimens, correlating IL-17RC expression with clinicopathological parameters and patient survival. Functional analyses were conducted using two OSCC cell lines (HSC3 and SCC25) subjected to IL-17RC knockdown, followed by assays evaluating cell viability, proliferation, migration, invasion, and response to radiation. In addition, immune cell migration toward cancer cells was assessed using a microfluidic chip.
High IL-17RC expression was associated with clinicopathological features related to tumor behavior and emerged as an independent predictor of improved disease-specific survival and disease-free survival. In vitro, IL-17RC knockdown in HSC3 cells increased proliferation and reduced immune cell recruitment. In SCC25 cells, IL-17RC depletion decreased migration and invasion. In both cell lines, IL-17RC knockdown reduced post-irradiation cell viability.
These findings indicate that elevated IL-17RC expression is independently associated with favorable clinical outcomes, supporting its potential as a prognostic biomarker in OSCC. Furthermore, the distinct in vitro effects observed across cell lines suggest that IL-17RC may differentially regulate pathways involved in proliferation, invasion, cell survival, and cancer–immune cell crosstalk. These observations may reflect the biological heterogeneity of OSCC and underscore the need for further investigation of IL-17RC within the tumor microenvironment.

Keywords
IL-17RC
oral squamous cell carcinoma
prognostic biomarker
tumor microenvironment.
Development of a Knowledge-Based AI System for Automated ECG Signal Classification and Clinical Risk Stratification
Identification of Secondary Bacterial Infection for RSV-infected children through 16srRNA Sequencing